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Cytotoxic T  lymphocyte (CTL) 1 responses to viruses, minor histocompatibility 
antigens, and haptens are regulated by both class-I and class-II gene products of 
the  major  histocompatibility complex  (MHC).  This  two-gene control is  best 
illustrated by the CTL response against the male antigen H-Y. In C57BL/6 (B6, 
H-2  b) mice generation of H-Y-specific CTL involves the presentation of H-Y by 
adherent cells in the context of the I-Ab-class-II molecule to T  helper cells; and 
presentation of the antigen by nucleated cells in the context of the H-2D  b class- 
I molecule to CTL precursors. Accordingly, anti-H-Y B6 T  helper cells are I- 
Ab-restricted and anti-H-Y B6 CTL are H-2 Db-restricted (1-3). 
Class-I  molecules function as immune-response (Ir) gene products regulating 
CTL responses against a variety of antigens (1, 2, 4-7). An opportunity to more 
precisely analyze this immunoregulatory function is provided by the availability 
of H-2 mutants. The H-2 K  b mutants have been used intensively in this respect, 
and they have profound effects on  the magnitude and specificity of H-2  K- 
restricted CTL responses. The pattern of cross-reactivity of antigen-specific B6 
CTL tested on a  panel of antigen-bearing H-2  K  b mutant target cells is quite 
similar for the CTL responses against Ectromelia virus,  LCM virus,  Vaccinia 
virus, SV 40, Sendai virus, H-4 and H-3 minor histocompatibility antigens, and 
the hapten AED (8-15). In these antigenic systems, the K  b mutant target cells to 
a  greater or  lesser extent show loss of Kb-restriction sites.  Subtle differences 
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between the various antigenic systems occur, indicating that different restriction 
sites  on  the  H-2  K b  molecule  are  used  for  different antigens.  Besides  CTL 
restriction specificities, the mutations also affect the capacity to respond. B6 and 
H-2 K b mutants vary in their ability to generate H-2-restricted CTL responses 
against  SV  40,  Sendal  virus  (12,  13)  H-4  and  H-3  minor  histocompatibility 
antigens (16) and VSV (Forman, personal communication). In all three systems, 
the bml mutant shows Ir defects and does not mount an H-2K-restricted CTL 
response. The mechanism of this type of Ir-gene-controlled nonresponsiveness 
is not known. 
Similar to the situation with the H-2 K b mutants, evidence was presented that 
two H-2 D b mutations, bml 3 and bml4, strongly influenced the H-2 Db-restricted 
CTL responses against the hapten AED and against Moioney leukemia virus (15, 
17).  We now report the effect of these mutations on the H-2 D-restricted CTL 
response against H-Y. 
The  results indicate unequivocally for the first time with  H-2  mutants that 
class  I  and class  II  MHC-determined CTL response defects complement each 
other in an F1 hybrid animal. Moreover, in this model evidence is presented that 
Ir genes may act at the level of both the T  cell repertoire and antigen presenta- 
tion. 
Materials and Methods 
Animals.  All mice were bred at the Central Laboratory of the Netherlands Red Cross 
bml3  bml4  Blood Transfusion Service.  The mutant strains B6.C-H-2  (bml3) and B6.C-H-2 
(bml4) (18) were raised from breeding stocks supplied by Dr. R. W. Melvold and Dr. D. 
W. Bailey (The Jackson Laboratory, Bar Harbor, ME), respectively. 
Immunization.  Unless otherwise mentioned, female mice were primed by one intraper- 
itoneal (i.p.) injection of 1.5 x  107 male spleen cells in 0.5 mi phosphate-buffered saline 
(PBS). 
Neonatal Tolerance Induction.  Female bm 14 or B6 mice were injected intraperitoneally 
within 24 h after birth with a mixture of 5 x  107 spleen and bone marrow cells from 
female (B6  x  bml4)F~  animals in a  volume of 0.1  ml.  Tolerance was  tested by skin 
grafting. 
In Vitro Generation of H-Y-Specific CTL.  CTL were generated as previously described 
(3). Spleen cells (108) from in vivo-primed female mice were stimulated with 2,500 rad- 
irradiated male spleen cells (108) in 80-ml culture medium for 5 d at 37°C in humidified 
air with 5% CO~. The culture medium consisted of Iscove's modified Dulbecco's medium 
(IMDM; Gibco Laboratories, Grand Island, NY) supplemented with 10% pooled human 
serum, penicillin (100  IU/ml), streptomycin (100 #g/ml), and 2-mercaptoethanol (2 x 
10  -5 M). 
Cell-mediated Lymphocytotoxicity.  Varying numbers of effector cells were added to 3 x 
51  104 Na25'CrO4 (  Cr)-Iabeled  target cells in 0.2 ml IMDM supplemented with 10% fetal 
calf serum (Gibco Laboratories) in wells of round-bottom microtiter plates and incubated 
for 3 h at 37°C in humidified air with 5% CO2. LPS- (30 #g/ml) induced lymphoblasts 
were used as target cells. After incubation, the supernatant was collected with the Titertek 
Supernatant Collection System (Flow Laboratories, Inc., Mclean, VA). The percentage 
specific 5~Cr release was calculated by the formula: 
cpm experimental well-backsxound SICr-release 
% specific lysis =  cpm 5% saponin release-background 51Cr-release X 100. 
The standard error of triplicate cultures was always less than 3% specific 5aCr release. DE  WAAL  ET  AL.  1539 
Results 
bml3 and  bml4 Mice Are Low Responders in  the CTL Response to H-Y.  H-Y- 
primed bml 3 and bml4 spleen cells restimulated in vitro with male syngeneic 
spleen cells did not generate H-Y-specific CTL (Table I). However, in a  small 
number of experiments ('~1  out of 10) we observed weak H-Y-specific CTL 
responses in these mutants, indicating that bml3 and bml4 are not complete 
CTL nonresponders to H-Y (data not shown). Different immunization proce- 
dures (s.c.;  i.v.; footpad immunization) or the addition of IL-2  to the culture 
medium during in vitro restimulation did not elevate the low CTL responsiveness 
of bm 13 and bm 14 to H-Y (data not shown). In contrast, H-Y-primed B6 spleen 
cells showed strong H-Y-specific CTL responses restricted by H-2 D  b (Table I). 
Furthermore, B6 anti-H-Y CTL were not able to lyse male bml 3 or male bml4 
target cells (Table I). This indicates that the mutations in bm 13 and bml 4 have 
altered extensively the B6 H-Y-specific restriction specificities. Allogeneic CTL 
specific for the mutated H-2 D b molecule could efficiently lyse bm 13 and bm 14 
target cells, indicating that defective expression of the H-2 D  molecule on the 
target cells cannot explain the above findings (Table II). 
Fine Spec~city of Alloimmune  CTL Directed Against H-2 D.  Effector cells were 
generated in all possible combinations between B6, bm 13, and bm 14 and tested 
against B6, bm 13, and bml 4  target cells. The results in Table II indicate that 
bml3  is  closer to  B6  than  is  bml4  with  respect to  CTL  allospecificities.  B6 
responder cells generated a  weak CTL response against bml3  alloantigen, in 
contrast to the strong response observed against bm 14. Furthermore, bm 14 anti- 
bml3  CTL lysed B6 target cells to the same extent as bml3 targets, whereas 
bm 13 anti-bm 14 CTL showed a much lower level of cross-reactivity against B6 
targets. Another interesting observation is the asymmetry in CTL responses. In 
contrast to the weak B6 anti-bm 13 CTL response, bm 13 responder cells generate 
strong alloreactivity against  B6.  bml3  anti-B6  CTL  and bml4  anti-B6  CTL 
crosskill, to some extent, bml4 and bml 3 targets, respectively. However, in the 
reverse direction, B6 anti-bml 3 and B6 anti-bml4 CTL do not show any cross- 
reactivity. Finally, it can be concluded from Table II that both bml 3 and bml4 
(although the latter to a lesser extent) share determinants with B6, as defined by 
allogeneic CTL. 
TABLE  I 
H-Y-Specific CTL Response in B6, bml3, and bml4 Mice 
CTL anti-  Target cells* 
H-Y*  B66  4R~ (k/b)  5R~ (b/d)  bml3d  bml4d  B69 
B6  t63 (9.7)  61 (13.6)  7 (4.3)  5 (3.8)  5 (4.7)  4 (3.1) 
bml3  3 (2.4)  3 (3.1)  4 (3.8)  3 (3.4)  4 (3.0)  3 (1.2) 
bml4  4 (4.8)  3 (1.8)  3 (3.5)  2 (2.4)  10 (4.5)  1 (2.2) 
* Female responder mice were primed in vivo and their spleen cells restimulated in vitro with male 
syngeneic spleen cells. 
* LPS blasts, H-2 K and -D alleles in parentheses. 
J 4R =  B10.A(4R); 5R =  B10.A(5R). 
I  Mean percentage specific cytotoxicity of eight experiments; SE in parentheses; effector-to-target 
ratio 16:1. 1540  CTL  RESPONSIVENESS  TO  H-Y 
TABLE  II 
Fine Specificity of  Alloimmune Cytotoxic T Lymphocytes Directed Against 
H-2 D 
AIIo-CTL* 
Target cells* 
bml3  bml4  B6 
B6 anti-bm 13  16  !  1  0 
B6 anti-bm  14  2  69  4 
bm 13 anti-B6  3  27  55 
bm 14 anti-B6  26  4  52 
bm 13 anti-bm 14  5  70  33 
bml4 anti-bml 3  57  3  56 
* 5  x  107  responder cells were  cultured  with 5  ×  107 stimulator cells 
(2,500 tad irr.) in 80 ml culture medium during 5 d at 37 °C, after which 
51  period the effector cells were tested on  Cr-labeled target cells. 
* LPS blasts. 
e Mean percentage specific 5~Cr-release of three experiments; effector to 
target cell ratio 16:1. 
(B6 × bml3)Fl and (B6 × bml4)F1  Hybrids Respond  to HoY Afier Sensitization with 
Male F1 or Male B6 Cells But Not with Mutant Male Cells.  (B6 ×  bml3)F1 and (B6 
×  bml4)F1 females, primed in vivo and restimulated in vitro with syngeneic F1 
male spleen cells, generated efficient H-Y-specific CTL responses. Like B6 anti- 
H-Y CTL, these F~ effectors preferentially lyse male target cells, expressing the 
H-2  Db-gene product: male B10.A(4R)  (KkD b) target cells were lysed, whereas 
male B 10.A(5R) (KbD  n) target cells were not lysed (Table IIIA). After sensitiza- 
tion of Fl females with male B6 spleen cell, identical results were obtained (Table 
IIIA). However, sensitization of (B6 ×  bml 3)F1 females with male bml 3 spleen 
cells or sensitization of (B6 ×  bml4)F1 females with male bml4 spleen cells did 
not result in the generation of H-Y-specific CTL (Table IIIA).  Finally, (B6 × 
bml3)F~ females were primed in vivo by either Fl or B6 male spleen cells and 
restimulated in vitro  with male bml 3  spleen cells and vice versa.  Also under 
these conditions we could not measure any H-Y-specific CTL activity (Table III 
B). 
Genetic Complementation  Between bml2,  bml3,  and  bml4 for H-Y-Specific  CTL 
Responses.  The I-A  b mutant bm 12 is a  nonresponder in CTL reactivity and T 
cell proliferation to H-Y  (3,  19).  Therefore,  it was of interest  to see whether 
bml2  could complement bml3  or bml4 in an Fl  hybrid for the H-Y-specific 
CTL response. From Table IV, it is clear that (bml2 x  bml3)F~ and (bml2 x 
bm 14)F1  hybrids  can  respond  against  H-Y,  indicating  transcomplementation 
between a class-II molecule (I-A  b) involved in the antigen-specific recognition by 
T  helper cells and a  class I  molecule (H-2  D u) involved in the antigen-specific 
recognition by CTL precursors. As expected, bml 3 and bml4 could not com- 
plement each other for the generation of H-Y-specific CTL (Table IV). 
Failure of B6 or D b Mutant Mice Tolerant  of Each Other to Respond  to Tolerogenic 
Allogeneic  Male  Cells.  The  mechanism  underlying  the  inability  of  bml4  to 
generate anti-H-Y CTL was further investigated by injecting female bml4 mice 
within 24 h after birth with a mixture of spleen and bone-marrow cells of (B6 X 
bml4)Fl female mice. These neonatally injected bml4 mice were tested after 8 DE  WAAL ET  AL.  1541 
TABLE  III 
H-Y-Specific CTL Response of(B6 x  bm13)Fl and (B6 x  bml4)F~ Mice 
Target cells* 
Sensitization to H-Y 
A. Responder mice  with*  FI~  4Rl~  5RI~  Fl~ 
(k]b)  (b/d) 
(B6 X bml3)Fl~  (B6 x bml3)Ficl  391  46  -2  4 
B6~  45  47  5  4 
bm 13c1  4  3  1  3 
(B6 X bml4)Ft9 
B. Responder mice* 
(B6 x bml4)Flc~ 
B6cl 
bml4c~ 
Primed in vivo with 
40  NT  NT  1 
42  NT  NT  2 
3  -1  2  2 
Restimulated  in vitro  Target cell# 
with  B6c~  B6~ 
(B6 x bml3)Fl9  (B6 x bm 13)Flc~  (B6 X bm 13)Flc~  681  4 
(B6 X bml3)Fic~  bml3c~ 
bml3c~  (B6 x bml3)Flc~  2  -1 
-2  3 
* Responder female mice were primed in vivo and their spleen cells restimulated  in vitro with the 
indicated  male spleen cells. 
* LPS blasts; H-2 K and -D alleles in parentheses. 
0 F~ hybrid target cells syngeneic with the responder haplotype were used. 
t  4R -- B10.A(4R); 5R = B10.A(5R). 
Percentage specific ~'Cr-release; effector to target cell ratio 16:1. 
NT, not tested. 
TABLE  IV 
Genetic Complementation of the H-Y-Specific CTL Response 
Target cells* 
(bml3 x  (bml3 x  Responder mice  Sensitization to H-Y with*  B6~  B6~  bml4)Fi¢5  bml4)Fl~ 
(bml2 x bml4)Fl~  (bml2 X bml4)Ftc~  45  !  4 
(bml2 x bml3)Fl~  (bml2 X bml3)Fic~  46  6 
(bml3 x bml4)F~  (bml3 X bml4)Flc~  5  2 
* Responder female mice were primed in vivo and their spleen cells restimulated  in vitro with the 
indicated  male spleen cells. 
* LPS blasts. 
! Percentage specific S~Cr-release; effector to target cell ratio 16:1. 
wk  for  tolerance  to  B6  alloantigens  and  for  their  capacity  to  generate  H-Y- 
specific  CTL  responses.  Table  IV  indicates  that  (a)  bml4  mice  can  mount 
efficient  CTL  responses  to  B6  alloantigens,  (b)  female  bml4  mice  neonatally 
injected with (B6 x  bm 14)F1 female cells are tolerant to B6 alloantigens, (c) these 
tolerant  mice can generate  excellent  CTL  responses  to third-party alloantigens 
(B10.D2),  and  (d) bml4  female cells  tolerant  to B6  female  alloantigens  do not 
mount an H-Y-specific CTL  response after priming in vivo and restimulation  in 
vitro with  (B6  x  bml4)F~  male cells.  Likewise,  female  B6 mice were rendered 
neonatally tolerant  for bm 14 alloantigens.  These  tolerant  B6 female  mice gen- 
erated excellent H-Y-specific CTL  responses after sensitization  with male B6 or 1542  CTL  RESPONSIVENESS TO  H-Y 
TABLE V 
Failure of  B6 or D b Mutant Mice Tolerant of  Each Other to Respond to AUogeneic Male Cells 
Priming in vivo  Target cells (LPS blasts) 
Responder mice  and restimulation  P815  (B6 x bm14)F~  (B6 x bm14)F~ 
in vitro with  (H_2  d)  d  9 
bm 149  (B6 x bm 14)Fld  51 *  44 
bm149 tol.B69  (B6 x bml4)Fid  7  1 
bm149 tol.B69  B10.D2 
B10.D2 ~  83  1 
B69 tol.bm 149  B68  43  3 
B69 tol.bm 149  bm 14~  0  3 
B69 toi.bm149  (B6 x  bml4)F~6  45  1 
* Percentage specific  cytotoxicity;  effector to target ratio 16:1. 
* Tolerant bm14 9mice were primed in vivo with (B6 x bml4)F,d and restimulated in vitro with 
either F~d cells or B10.D2 9 cells. 
male (B6 x  bml4)F~  spleen cells, but failed to respond after sensitization  with 
male bm14 spleen cells. Thus, H-Y-specific CTL responses were only observed 
in neonatally tolerized animals when responder type T  cells and responder type 
antigen-presenting cells (apc) were used (Table V). 
Discussion 
Our findings clearly demonstrate that the CTL response to H-Y is regulated 
by H-2 D  gene products.  Structural  alterations  of the H-2 O b molecule in  the 
bm 13 and bm 14 mutant strains lead to changes in restriction speciflcities and in 
responsiveness. This is further support for the notion that class-I determinants, 
recognized by H-2 K/D-restricted  CTL, act as Ir-gene products (1-7,  13,  16, 
17).  Changes  in restriction  specificities in bml3 and  bml4 compared with  B6 
have been observed in three other systems: (a) H-2 Db-restricted Moloney virus- 
specific CTL do not iyse virus~infected bm13 or bm14 target cells (17); (b) H-2 
Db-restricted CTL specific for the hapten AED are unable to kill hapten-modified 
bm 13 and bm 14 targets (15), and (c) Melvold et al. (20) reported that the biologic 
activity of a  mutant  non-H-2  histocompatibility antigen  was dependent on the 
simultaneous presence of both the mutant  minor  H  antigen  and  H-2 D b. The 
bm13  mutant  could replace  H-2 D b in this  latter interaction,  but bm14 could 
not.  This corresponds with our data that bm 13 is closer to B6 than bm14 with 
respect to allogeneic CTL determinants  (Table II). The results in Table II also 
show that bml 3 and bm14 still  share  CTL allodeterminants  with B6, which is 
apparently not reflected in the presence of shared restriction specificities for H- 
2  Db-restricted  CTL  responses  to  H-Y,  Moloney  virus,  or  AED.  It  can  be 
envisaged,  however,  that  different  antigens  (like  the  minor  histocompatibility 
antigen  reported above) use different restriction sites on the H-2 D b molecule. 
Apart  from restriction  specificities, the bm 13 and  bml4  mutations also affect 
the magnitude of CTL responses: both mutants are CTL nonresponders to H-Y 
(this paper) and bm14 does not mount a  CTL response to Moloney virus (17). 
However, bm 13 does respond  to Moloney virus, although  the restriction  pref- 
erence  is  shifted  to  H-2  K b  (17).  Thus,  although  a  close  relationship  exists DE  WAAL  ET  AL.  1543 
between CTL-restriction specificities, CTL regulating determinants and CTL- 
allospecificities, in some instances CTL regulating determinants on one class I 
molecule influence the CTL response restricted by another class I molecule (17, 
21). 
Our findings are somewhat in contrast with data of Simpson et al. (22) who 
showed that bm 14 can generate H-Y-specific CTL, whereas we observed weak 
H-Y-specific CTL responses only in a minority of experiments. 
From our analysis of the CTL  nonresponsiveness to  H-Y of the bml2  I-A 
mutant,  we concluded that  T  helper cells recognize the  H-Y  antigen  in  the 
context of the I-Abal3 (class-II) molecule on adherent cells, whereas CTL precur- 
sors recognize the antigen in the context of the D  b (class-I) molecule on adherent 
as well as nonadherent cells. With spleen cells from primed animals, the require- 
ment for T  helper cells could be bypassed with interleukin-2 (3).  The current 
finding that the bml2 class-II mutant on the one hand and the bml3 and bml4 
class-I mutants on the other complement each other for the H-Y-specific CTL 
response, further supports the idea that two separate Ir gene-controlled pathways 
are needed for this response (2). Moreover, the complementation data show that 
the need for tolerance of the mutant class-II and class-I  molecules in the (bm 12 
× bml3)F~ and (bml2 ×  bml4)Fx hybrids does not create deletions in the I-A  b- 
restricted T  helper cell and Db-restricted CTL repertoire for H-Y. The same 
holds for the Db-restricted CTL repertoire for H-Y in the (B6 ×  bml 3)F~ and 
(B6 ×  bml4)Fl hybrids. 
The two main observations pertinent to the mechanism of H-2 D-controlled 
nonresponsiveness are the following: 1) (responder × nonresponder)Fl cells react 
against antigen presented on F~ or responder parental cells but do not respond 
to antigen presented on nonresponder parental cells; 2) B6 or D b mutant mice 
tolerant of each other fail  to  respond to  the  male antigen presented on  the 
tolerogenic allogeneic cell. Observation 1 is the classical  response pattern in Ir 
gene-controlled nonresponsiveness, although we recently documented an im- 
portant exception to this rule in experiments on the nonresponsiveness to H-Y 
of the bml2  I-A mutant (3).  The classical response pattern can be explained 
along two main lines: lack of appropriate antigen presentation, or deletion(s) in 
the  T  cell  repertoire  (23-25).  Observation  2)  is  in  line  with  other  recent 
experiments demonstrating holes in the allorestricted T  cell repertoire. Thus, it 
was shown that  B6  mice neonatally tolerant of H-2  k did not generate a  CTL 
response to H-2  k plus vaccinia virus (26), although B6 spleen cells acutely depleted 
of anti-H-2  k reactivity by filtration through semiallogeneic recombinant or F~ 
hosts did respond to  H-2  k plus vaccinia virus (26).  In the proliferative T  cell 
response against the synthetic polypeptide GLT, it was seen that elimination by 
BUdR and light of T  cells specific for alloantigen X can create a deletion in the 
T  cell repertoire restricted by alloantigen Y (27). 
In contrast to our experiments concerning allorestricted CTL responses in a 
responder/nonresponder neonatal tolerance situation, excellent allorestricted T 
cell populations  specific for minor histocompatibility antigens and the hapten 
TNP were seen following neonatal tolerance induction using two responder type 
strains (28, 29). H-2 Ir gene-controlled nonresponsiveness is currently attributed 
to the absence of functional T  cells rather than inappropriate antigen presenta- 1544  CTL  RESPONSIVENESS  TO  H-Y 
tion  (30-33),  the  evidence  being  mainly  based  on  high  responses  of  high- 
responder  type  T  cells  to  antigen  presented  on  low-responder  type antigen- 
presenting cells (apc). 
However, the situation  may not be as simple as that,  because (a) the antigen 
seen on apc in the context of allogeneic MHC molecules is different from that 
seen on syngeneic apc and may therefore be under a different Ir gene control as 
in fact demonstrated (30) (b). Cytochrome c-specific T  cell hybridomas of B 10.A 
and B 10.A(5R) origin only responded to pigeon cytochrome c fragment 81-104 
when this antigen  was presented on high-responder  B10.A apc,  but not when 
presented  on  low-responder  B10.A(5R)  apc.  This  indicates  that  the  relevant 
MHC molecule (Ia in this case) on the apc determined whether these hybridomas 
were triggered  (34).  In  later  experiments,  these results were extended  to  the 
population  level (35).  Therefore,  in  the final  analysis the  various interactions 
between  antigen,  MHC  molecules,  and  T  cell  receptors  probably  determine 
whether a  reaction is triggered.  This notion does not rule out that  nonrespon- 
siveness may be the result of lack of T  cells in the repertoire that are capable of 
being triggered by a particular antigen-MHC combination.  For example, in our 
analysis of the  CTL  nonresponsiveness  to  H-Y of the bm 12  I-A mutant,  only 
evidence  for  a  deletion  in  the  T  cells  was  found.  In  the  neonatal  tolerance 
experiments  with the bml3  and bm 14 nonresponders  to H-Y, a  response was 
only seen with responder  type T  cells and responder  type apc, indicating  that 
both  the  T  cell  source and  the  MHC  type of the  apc  have  to  be  taken  into 
account in this experimental situation. 
Summary 
The cytotoxic T-lymphocyte (CTL) response against the male-specific antigen 
H-Y in  C57BL/6  (B6,  H-2  b) mice is regulated  by the  I-A  b and  D b molecules. 
From previous studies, we concluded that the bm 12 I-A  b mutant does not respond 
to H-Y, because of a deletion in its T-helper-cell repertoire. We now demonstrate 
that two D b mutants,  bml3 and bml4, also fail to generate a  CTL response to 
H-Y. The  bml2  class-II mutant  on one hand and  the bml3 and  bml4 class-I 
mutants  on  the  other  complemented  each  other  for  the  H-Y-specific  CTL 
response in (bml2 x  bml 3)Fl and (bml2 x  bml4)F1 hybrids. This indicates that 
the  need  for  tolerance  of the  mutant  class  II  and  class  I  molecules  in  these 
hybrids does not create deletions in  the I-Ab-restricted T  helper cell and  D b- 
restricted CTL repertoire for H-Y. This study constitutes the first demonstration 
with H-2 mutants that a  CTL response controlled by class I and class II MHC 
molecules  is  complemented  in  an  F1  cross  between  a  class  I  and  a  class  II 
nonresponder. (B6 x  bml 3)Fl and (B6 X bml4)F~ hybrids only responded to H- 
Y when the antigen was presented on F1 or B6 antigen-presenting cells (apc) but 
not on D b mutant apc. B6 or D b mutant responders rendered neonatally tolerant 
of each other failed to respond to the H-Y antigen presented on the tolerogenic 
allogeneic cell. In the tolerized animals, a response was only seen with responder 
(B6) type T  cells and responder  type (B6) apc, indicating  that  both the T  cell 
source and the MHC type of the apc have to be taken into account in this system. 
Thus,  Ir genes may act at the  level of both the  T  cell repertoire  and antigen 
presentation. DE  WAAL ET AL.  1545 
Received for publication 31 May 1983. 
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